ESC/ERS guidelines: recommendations for pulmonary veno-occlusive disease (PVOD)
| Statement | Class# | Level¶ |
| Referral of patients with PVOD to a transplant centre for evaluation is indicated as soon as the diagnosis is established | I | C |
| Patients with PVOD should be managed only in centres with extensive experience in PAH due to the risk of lung oedema after the initiation of PAH-specific drug therapy | IIa | C |
PAH: pulmonary arterial hypertension. #: class of recommendation; ¶: level of evidence. Reproduced from 1 with permission from the publisher.